Antiangiogenic drugs as a novel anticancer therapeutic strategy - Which are the more promising agents? What are the clinical developments and indications?

被引：16

作者：

Gasparini, G ^{[1
]}

机构：

[1] Azienda Osped Bianchi Melacrino Morelli, Div Oncol, I-89100 Reggio Calabria, Italy

来源：

关键词：

D O I：

10.1016/S1040-8428(97)10001-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：147 / 162

页数：16

共 122 条

[1] ABE J, 1994, CANCER RES, V54, P3407
[2] Alessandro R., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P184
[3] [Anonymous], 1994, RADIAT ONCOL INVEST
[4] STIMULATION OF HUMAN B-LYMPHOCYTE PROLIFERATION BY AGM-1470, A POTENT INHIBITOR OF ANGIOGENESIS
ANTOINE, N
BOURS, V
HEINEN, E
SIMAR, LJ
CASTRONOVO, V
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (02) : 136 - 139
[5] ASANO M, 1995, CANCER RES, V55, P5296
[6] ANGIOGENESIS INHIBITION - A REVIEW
AUERBACH, W
AUERBACH, R
[J]. PHARMACOLOGY & THERAPEUTICS, 1994, 63 (03) : 265 - 311
[7] Cancer undefeated
Bailar, JC
Gornik, HL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (22) : 1569 - 1574
[8] TUMOR VASCULATURE - A POTENTIAL THERAPEUTIC TARGET
BAILLIE, CT
WINSLET, MC
BRADLEY, NJ
[J]. BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 257 - 267
[9] Belotti D, 1996, CLIN CANCER RES, V2, P1843
[10] STIMULATION OF NK CELL, T-CELL, AND MONOCYTE FUNCTIONS BY THE NOVEL IMMUNOMODULATOR LINOMIDE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A PILOT-STUDY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
BENGTSSON, M
SIMONSSON, B
CARLSSON, K
NILSSON, B
SMEDMYR, B
TERMANDER, B
OBERG, G
TOTTERMAN, TH
[J]. TRANSPLANTATION, 1992, 53 (04) : 882 - 888